Ayalew Tefferi1. Show Affiliations » 1. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » Activin Receptors, Type II/therapeutic useDrug ApprovalDrug DiscoveryHumansImmunoglobulin Fc Fragments/therapeutic useMyelodysplastic Syndromes/drug therapyMyelodysplastic Syndromes/pathologyMyelodysplastic-Myeloproliferative Diseases/drug therapyMyelodysplastic-Myeloproliferative Diseases/pathologyOligonucleotides/therapeutic useRecombinant Fusion Proteins/therapeutic useThrombocytosis/drug therapyThrombocytosis/pathology
Substances： See more » Immunoglobulin Fc FragmentsOligonucleotidesRecombinant Fusion ProteinsluspaterceptActivin Receptors, Type IIimetelstat
Year: 2021 PMID： 33861878 DOI： 10.1002/ajh.26197
Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047